Label Suit Should Be Erased, Drugmakers Tell NJ Judges
The makers of generic Reglan told the New Jersey Supreme Court on Monday that claims they failed to warn consumers adequately of the heartburn medication's neurological risks should be tossed because...To view the full article, register now.
Already a subscriber? Click here to view full article